688192 迪哲醫藥
按盤價 
56.330 +9.390 (+20.004%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -7.559 | -102.722 | -162.312 | -84.976 | -34.871 |
| 總資產報酬率 ROA (%) | -3.177 | -32.366 | -52.624 | -61.913 | -30.491 |
| 投入資產回報率 ROIC (%) | -3.656 | -39.241 | -64.724 | -71.379 | -33.498 | 邊際利潤分析 |
| 銷售毛利率 (%) | 95.925 | 95.727 | 97.411 | 96.478 | -- |
| 營業利潤率 (%) | -38.162 | -95.660 | -261.545 | -1,213.308 | -- |
| 息稅前利潤/營業總收入 (%) | -35.329 | -91.986 | -254.688 | -1,207.359 | -- |
| 淨利潤/營業總收入 (%) | -38.295 | -95.929 | -261.087 | -1,213.419 | -- | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 116.758 | 111.200 | 106.098 | 104.851 | 106.708 |
| 價值變動淨收益/利潤總額(%) | -7.010 | -3.302 | -1.538 | -2.033 | -5.730 |
| 營業外收支淨額/利潤總額(%) | -0.025 | 0.100 | -0.176 | 0.000 | 0.000 | 償債能力分析 |
| 流動比率 (X) | 2.820 | 2.215 | 1.272 | 2.030 | 5.928 |
| 速動比率 (X) | 2.779 | 2.178 | 1.216 | 1.978 | 5.908 |
| 資產負債率 (%) | 59.005 | 56.847 | 88.360 | 43.288 | 15.535 |
| 帶息債務/全部投入資本 (%) | 52.973 | 47.746 | 82.011 | 27.806 | 0.561 |
| 股東權益/帶息債務 (%) | 86.714 | 106.684 | 17.448 | 242.222 | 17,006.872 |
| 股東權益/負債合計 (%) | 69.438 | 75.804 | 12.758 | 131.011 | 543.703 |
| 利息保障倍數 (X) | -12.515 | -24.409 | -39.802 | -202.965 | 90.190 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 56.032 | 38.406 | 37.778 | 189.449 | -- |
| 存貨周轉天數 (天) | 302.110 | 426.294 | 1,305.815 | 1,597.977 | -- |
| 備註： | 即時報價更新時間為 14/07/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
